The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review
- PMID: 30380986
- PMCID: PMC6605784
- DOI: 10.1080/21645515.2018.1540807
The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review
Abstract
Pregnant women are at increased risk of morbidity and mortality from influenza and are recognized as a priority group for influenza vaccination. Despite this, uptake is often poor and one reason cited for this is concerns about safety. The objective of this study was to perform a systematic review of the safety of inactivated influenza vaccination (IIV) in pregnancy. Studies were included if they were: (i) observational or experimental design; (ii) included a comparator group comprising of unvaccinated pregnant women; (iii) comprised of either seasonal IIV or monovalent H1N1 IIV (including adjuvanted vaccines); and (iv) addressed one of the following outcomes: preterm birth (PTB), small for gestational age (SGA), fetal death (including stillbirth or spontaneous abortion), low birth weight (LBW) or congenital abnormalities. Two reviewers screened abstracts and titles and selected full texts for retrieval. Crude odds ratios were calculated from reported event rates, using binomial standard errors. Adjusted odds ratios, hazard ratios and relative rates were extracted as reported in each paper. After removal of duplicates and full text eligibility assessment, 40 studies remained. The aOR for PTB was 0.87 (0.78-0.96), for LBW 0.82 (0.76-0.89), congenital abnormality 1.03 (0.99-1.07), SGA 0.99 (0.94-1.04) and stillbirth 0.84 (0.65-1.08). This study contributes to the increasing body of safety data for IIV in pregnancy and reports a protective effect on PTB and LBW.
Keywords: immunization; influenza; pregnancy; safety; vaccination.
Figures
Similar articles
-
The Effects of Influenza Vaccination during Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis.Am J Perinatol. 2016 Sep;33(11):1104-14. doi: 10.1055/s-0036-1586101. Epub 2016 Sep 7. Am J Perinatol. 2016. PMID: 27603545 Review.
-
Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016.Drug Saf. 2017 Feb;40(2):145-152. doi: 10.1007/s40264-016-0482-1. Drug Saf. 2017. PMID: 27988883 Free PMC article.
-
A systematic review and meta-analysis of fetal outcomes following the administration of influenza A/H1N1 vaccination during pregnancy.Int J Gynaecol Obstet. 2018 May;141(2):141-150. doi: 10.1002/ijgo.12394. Epub 2017 Dec 18. Int J Gynaecol Obstet. 2018. PMID: 29149524 Review.
-
Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.Vaccine. 2013 Oct 17;31(44):5026-32. doi: 10.1016/j.vaccine.2013.08.097. Epub 2013 Sep 7. Vaccine. 2013. PMID: 24016809
-
The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study.Clin Infect Dis. 2019 Jan 18;68(3):402-408. doi: 10.1093/cid/ciy517. Clin Infect Dis. 2019. PMID: 30475988
Cited by
-
Clinical analysis of influenza in the neonatal intensive care unit.Ital J Pediatr. 2024 Sep 18;50(1):184. doi: 10.1186/s13052-024-01742-6. Ital J Pediatr. 2024. PMID: 39294774 Free PMC article.
-
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales.NPJ Vaccines. 2024 Aug 14;9(1):147. doi: 10.1038/s41541-024-00934-9. NPJ Vaccines. 2024. PMID: 39143081 Free PMC article.
-
Potential Cost-Effectiveness of Maternal Influenza Immunisation in Low-Income Countries: An Explorative Modelling Study and Value of Information Analysis to Guide Future Clinical Research.Vaccines (Basel). 2024 Feb 23;12(3):232. doi: 10.3390/vaccines12030232. Vaccines (Basel). 2024. PMID: 38543866 Free PMC article.
-
Lack of association between COVID-19 vaccines and miscarriage onset using a case-crossover design.Sci Rep. 2024 Mar 27;14(1):7275. doi: 10.1038/s41598-024-57880-8. Sci Rep. 2024. PMID: 38538736 Free PMC article.
-
The PRotective Effect of Maternal Immunisation on preTerm birth: characterising the Underlying mechanisms and Role in newborn immune function: the PREMITUR study protocol.Front Immunol. 2023 Dec 20;14:1212320. doi: 10.3389/fimmu.2023.1212320. eCollection 2023. Front Immunol. 2023. PMID: 38187392 Free PMC article.
References
-
- World Health Organization The weekly epidemiological record. Geneva. 2012;87:201–216.
-
- Centers for Disease Control and Prevention Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunisation Practices (ACIP) 2009. MMWR Recomm Rep. 2009;58:1–86. - PubMed
-
- Fell DB, Bhutta ZA, Hutcheon JA, Karron RA, Knight M, Kramer MS, Monto AS, Swamy GK, Ortiz JR, Savitz DA. Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: montreal, Canada, September 30-October 1, 2015. Vaccine. 2017. April 28;35(18):2279–2287. doi:10.1016/j.vaccine.2017.03.056. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical